The Enterprise Value as of September 2024 (TTM) for Syndax Pharmaceuticals, Inc. (SNDX) is 1.52B

According to Syndax Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.52B. This represents a change of 4.19% compared to the average of 1.46B of the last 4 quarters.

Syndax Pharmaceuticals, Inc. (SNDX) Historical Enterprise Value (quarterly & annually)

How has SNDX Enterprise Value performed in the past?

The mean historical Enterprise Value of Syndax Pharmaceuticals, Inc. over the last ten years is 532.00M. The current 1.52B Enterprise Value has changed 28.49% with respect to the historical average. Over the past ten years (40 quarters), SNDX's Enterprise Value was at its highest in in the March 2024 quarter at 1.91B. The Enterprise Value was at its lowest in in the June 2015 quarter at 0.

Syndax Pharmaceuticals, Inc. (SNDX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Syndax Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Syndax Pharmaceuticals, Inc. (SNDX) Average Enterprise Value

How has SNDX Enterprise Value performed in the past?

The current Enterprise Value of Syndax Pharmaceuticals, Inc. (SNDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Syndax Pharmaceuticals, Inc. (SNDX) Enterprise Value vs. Peers

How is SNDX’s Enterprise Value compared to its peers?

Syndax Pharmaceuticals, Inc.’s Enterprise Value is greater than Cogent Biosciences, Inc. (1.08B), greater than Cullinan Oncology, Inc. (930.13M), greater than KalVista Pharmaceuticals, Inc. (506.03M), greater than Mersana Therapeutics, Inc. (138.92M), greater than Pliant Therapeutics, Inc. (762.35M), less than Revolution Medicines, Inc. (6.80B), greater than Viridian Therapeutics, Inc. (813.50M), greater than Inozyme Pharma, Inc. (343.89M), greater than Aerovate Therapeutics, Inc. (24.46M), less than Keros Therapeutics, Inc. (1.58B), greater than Mineralys Therapeutics, Inc. (490.57M), greater than Replimune Group, Inc. (632.78M), less than Vaxcyte, Inc. (11.96B), greater than Larimar Therapeutics, Inc. (486.93M), less than Merus N.V. (2.79B), greater than Sutro Biopharma, Inc. (437.33M), less than Cytokinetics, Incorporated (6.96B), less than DICE Therapeutics, Inc. (2.21B), less than Edgewise Therapeutics, Inc. (1.60B), less than Karuna Therapeutics, Inc. (12.43B), less than Dyne Therapeutics, Inc. (2.73B),

Build a custom stock screener for Syndax Pharmaceuticals, Inc. (SNDX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syndax Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Syndax Pharmaceuticals, Inc. (SNDX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Syndax Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.